Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Kindler Insider Profile
4 Followers
Jeffrey Kindler, Director at vTv Therapeutics, holds 23.01K shares in Perrigo Company (Ticker: PRGO), holds 393.36K shares in Precigen (Ticker: PGEN), holds 0.00 shares in PPD (Ticker: PPD).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+8.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Kindler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Kindler
Jeffrey Kindler's Trading History
vTv Therapeutics
Mar 11, 2020
Director
Uninformative Buy
31.50K
$639.80K
Perrigo Company
May 16, 2024
Director
Uninformative Buy
137.71K
$602.55K
PPD
Dec 08, 2021
―
Uninformative Sell
5.60M
$0.00
Terns Pharmaceuticals
―
Director
―
―
Precigen
Mar 18, 2024
Director
Uninformative Buy
69.00K
$578.24K
Pfizer
May 27, 2010
Former Chairman & CEO, Director
Uninformative Sell
―
$23.19M
Chipotle
May 16, 2014
Director
Uninformative Buy
―
$95.76K
SIGA Technologies
May 22, 2020
Director
Uninformative Buy
89.85K
$985.60K
List of latest transactions for each holding click on a transaction to see Jeffrey Kindler's performance on stock
You May Also Like
Jeffrey Kindler insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Kindler?
The percentage of profitable transactions made by Jeffrey Kindler is 60%.
What is the average return per transaction made by Jeffrey Kindler?
The average return per transaction made by Jeffrey Kindler is 8.20%.
What stocks does Jeffrey Kindler hold?
Jeffrey Kindler holds: VTVT, PRGO, PPD, TERN, PGEN, PFE, CMG, SIGA stocks.
What was Jeffrey Kindler’s latest transaction?
Jeffrey Kindler latest transaction was an Uninformative Buy of $137.71K.
What was Jeffrey Kindler's most profitable transaction?
Jeffrey Kindler’s most profitable transaction was an Informative Sell of PGEN stock on August 15, 2022. The return on the trade was 41.60%.
What is Jeffrey Kindler's role in vTv Therapeutics?
Jeffrey Kindler's role in vTv Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.